期刊文献+

关注药物相互作用细节,准确指导临床药物治疗 被引量:8

下载PDF
导出
摘要 药物相互作用(drug interraction)指同时或相隔一定时间内联合应用2种或2种以上药物,一种药物受到另一种药物的影响,由于其间或与人体间的作用,改变了一种药物原有性质、体内过程和组织对药物的敏感性,或改变药物的效应和毒性。药物相互作用的结果是双相的,一种结果对患者是有裨益的,使药理作用协同、疗效增强、毒性降低或不良反应减少;但另一种是有危害的,使药理作用拮抗、疗效降低、毒性增强或不良反应增加,有时会带来严重甚至危及生命的后果,这是临床所不期望的,必须注意规避和警惕。鉴于临床研究的方法、设计、观察终点的不同,对不同药物相互作用也会持有截然相反的观点和结论,例如质子泵抑制剂+氯吡格雷的联合。因此,必须重视大样本的循证医学研究,探索在临床上的真正、实际意义,批判性地看待体外研究结果,仔细权衡,"两利相亲取其重"、"两害相权取其轻"。此外,药物相关基因的多态性以及患者基因的变异、肝药物代谢酶活性的差异,均是导致个体对药品反应出现差异的重要原因,应当引起临床的关注和探索。
作者 刘治军
出处 《中国医院用药评价与分析》 2012年第3期193-197,共5页 Evaluation and Analysis of Drug-use in Hospitals of China
  • 相关文献

参考文献24

  • 1Monahan BP, Ferguson CL, Killeavy ES,et al. Torsades de pointes occurring in association with terfenadine use [ J ]. JAMA, 1990,264 (21) :2788.
  • 2刘治军,傅得兴,汤光.FDA药物相互作用研究指南(草案)2006版解读[J].国际药学研究杂志,2008,35(1):50-58. 被引量:28
  • 3Ndanusa BU, Mustapha A, Abdu-Aguye I. The effect of single does of rifampicin on the pharmacokinetics of oral nifedipine[ J]. J Pharm Biomed Anal, 1997,15 (9-10) : 1571.
  • 4Guerret M, Francheteau P, Hubert M. Evaluation of effects of terbinafine on single oral dose pharmacokinetics and anticoagulant actions of warfarin in healthy volunteers [ J 1. Pharmacotherapy, 1997,17 (4) :767.
  • 5刘治军,刘宁,孙春华,迟家敏.氟西汀和圣约翰草提取物对环孢素体外经CYP3A4代谢的影响[J].中国新药杂志,2009,18(2):155-158. 被引量:7
  • 6Rengelshausen J, Banfield M, Riedel KD, et al. Opposite effects of short-term and long-term St John' s wort intake on voriconazole pharmacokinetics [ J ]. Clin Pharmacol Ther,2005,78( 1 ) :25.
  • 7Moore LB, Goodwin B, Jones SA, et al. St. John' s wort induces hepatic drug metabolism through activation of the pregnane X receptor [ J ]. Proc Natl Acad Sci USA, 2000, 97(13) :7500.
  • 8Durr D, Stieger B, Kullak-Ublick GA, et al. St John' s wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4 [ J ]. Clin Pharmacnl Ther, 2000,68 (6) :598.
  • 9Sviland L, Robinson A, Proctor SJ, et al. Interaction of cimetidine with oral melphalan. A pharmacokinetic study [ J ]. Cancer Chemother Pharmacol, 1987,20 ( 2 ) : 173.
  • 10Yasui-Furukori N, Takahata T, Nakagami T, et al. Different inhibitory effect of fluvoxamine on omeprazole metabolism between CYP2C19 genotypes [ J]. Br J Clin Pharmacol,2004,57 (4) :487.

二级参考文献14

  • 1刘治军,傅得兴,孙春华,张亚同.环孢素与其他药物相互作用的临床研究[J].药物不良反应杂志,2006,8(3):197-201. 被引量:8
  • 2DEW MA, ROTH LH, SCHULBERG HC, et al. Prevalence and predictors of depression and anxiety-related disorders during the year after heart transplantation [ J ]. Gen Hosp Psychiatry, 1996, 18(6 Suppl) :48S -61S.
  • 3MADABUSHI R, FRANK B, DREWELOW B, et al. Hyperforin in St. John's wort drug interactions [ J ]. Eur J Clin Pharmacol, 2006, 62 ( 3 ) :225 - 233.
  • 4DIXON M. The determination of enzyme inhibitor constants[ J ]. Biochem J,1953, 55(1) :170 - 171.
  • 5KENWORTHY KE, BLOOMER JC, CLARKE SE,et al. CYP3A4 drug interactions: correlation of 10 in vitro probe substrates[ J ]. Br J Clin Pharmacol,1999, 48(5) :716 -727.
  • 6CRESPI CL, STRESSER DM. Fluorometric screening for metabolism-based drug-drug interactions [ J ]. J Pharmacol Toxicol Methods,2000, 44(1) :325 - 331.
  • 7TUCKER GT, HOUSTON JB, HUANG SM. Optimizing drug development: strategies to assess drug metabolism/transporter interaction potential-toward a consensus [ J]. Clin Pharmacol Ther, 2001, 70(2) :103 - 114.
  • 8ZHOU S, KESTELL P, BAGULEY BC, et al. Preclinical factors influencing the relative contributions of Phase Ⅰ and Ⅱ enzymes to the metabolism of the experimental anti-cancer drug 5,6-dimethylxanthenone-4-acelic acid [ J ]. Biochem Pharmacol, 2003, 65 (1):109-120.
  • 9HORTON RC, BONSER RS. Interaction between cyclosporin and fluoxetine [ J ]. BMJ, 1995, 311 ( 7002 ) :422.
  • 10OBACH RS. Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression [ J ]. J Pharmacol Exp Ther , 2000, 294 (1) :88 -95.

共引文献33

同被引文献80

引证文献8

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部